Abstract
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) was established in 2003 as an international collaborative group focused on psoriatic disease. GRAPPA has matured and become the foremost research and education society for psoriasis and psoriatic arthritis in the world, involving dermatologists and rheumatologists from many countries. GRAPPA collaborates with other societies including the ACR, EULAR, SPARTAN, ASAS, and OMERACT in fostering its goals. As an investment in the future, GRAPPA nurtures young researchers and clinicians interested in psoriasis and PsA in order to develop the next generation of leaders in these fields of medicine.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mease P, Gladman D, Krueger G, Antoni C. Psoriatic arthritis and psoriasis. Ann Rheum Dis. 2005;64(Suppl II):1–117.
Taylor WJ, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–73.
Chandran V, Schentag CT, Gladman DD. Sensitivity of the Classification of psoriatic arthritis (CASPAR) Criteria in early psoriatic arthritis. Arthritis Rheum (Arthritis Care & Research). 2007;57:1560–3.
D’Angelo S, Mennillo GA, Cutro MS, Leccese P, Nigro A, Padula A, Olivieri I. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol. 2009;36:368–70.
Coates L, Conaghan PG, Emery P, Green MJ, Ibrahim G, MacIver H, Helliwell PS. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 2012;64:3150–5.
Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis when applied to patients attending a family medicine clinic. J Rheumatol. 2008;35:2069–70.
Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthritis. A review of currently available measures. Arthritis Rheum. 2004;50:24–35.
Gladman DD, Mease P, Krueger G, van der Heijde D, Antoni C, Helliwell P, et al. Outcome measures in psoriatic arthritis (PsA): OMERACT VII Psoriatic Arthritis Workshop. J Rheumatol. 2005;32:2262–9.
Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, FitzGerald O, et al. Consensus on a core set of domains for psoriatic arthritis. OMERACT 8 PsA Module Report. J Rheumatol. 2007;34:1167–70.
Tillett W, Eder L, De Wit M, Gladman D, FitzGerald O, Goel N, et al. Enhanced patient involvement and the need to revise the core set- report from the Psoriatic Arthritis workshop at OMERACT 2014. J Rheumatol. 2015;42:2198–203.
Gladman DD, Inman R, Cook R, Maksymowych W, Braun J, Davis JC, et al. International spondyloarthritis inter-observer reliability exercise – the INSPIRE study: I. Assessment of spinal measures. J Rheumatol. 2007;34:1733–9.
Gladman DD, Inman R, Cook R, Maksymowych W, Braun J, Davis JC, et al. International spondyloarthritis inter-observer reliability exercise – the INSPIRE study: II. Assessment of peripheral joints, enthesitis and dactylitis. J Rheumatol. 2007;34:1740–5.
Chandran V, Gottlieb AB, Cook RJ, Callis Duffin K, Garg A, Helliwell PS, et al. International Multi-centre Psoriasis and Psoriatic Arthritis Reliability Trial (GRAPPA-IMPART): assessment of skin, joints, nails and dactylitis. Arthritis Rheum (Arthritis Care & Res). 2009;61:1235–42.
Cauli C, Gladman D, Mathieu A, Olivieri I, Porru G, Tak PP, GRAPPA 3PPsA Study Group. Patient global assessment in psoriatic arthritis (PsA). A multicentre GRAPPA and OMERACT study. J Rheumatol. 2011;38:898–903.
Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis. 2013;72:986–91.
Gottlieb AB, Armstrong AW, Christensen R, Garg A, Duffin KC, Boehncke WH, et al. The international dermatology outcome measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting. J Rheumatol. 2014;41:1227–9.
Gladman DD, Chandran V. Review of clinical registries of psoriatic arthritis: lessons learned? Value for the future? Curr Rheumatol Rep. 2011;13:346–52.
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. The Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat Genet. 2009;41:199–204.
Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012;44:1341–8.
Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, et al. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun. 2015;6:6046.
FitzGerald O, Chandran V. Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39:427–30.
Callis DK, Armstrong AW, Mease PJ. Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting. J Rheumatol. 2013;40:1455–6.
Gladman DD, Mease PJ. Towards international guidelines for the management of psoriatic arthritis. J Rheumatol. 2006;33:1228–30.
Soriano ER, McHugh NJ. Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol. 2006;33:1422–30.
Nash P. Therapies for axial disease in psoriatic arthritis. A systematic review. J Rheumatol. 2006;33:1431–4.
Ritchlin CT. Therapies for psoriatic enthesopathy. A systematic review. J Rheumatol. 2006;33:1435–8.
Helliwell PS. Therapies for dactylitis in psoriatic arthritis. A systematic review. J Rheumatol. 2006;33:1439–41.
Cassell S, Kavanaugh AF. Therapies for psoriatic nail disease. A systematic review. J Rheumatol. 2006;33:1452–6.
Boehncke WH, Prinz J, Gottlieb AB. Biologic therapies for psoriasis. A systematic review. J Rheumatol. 2006;33:1447–51.
Strober BE, Siu K, Menon K. Conventional systemic agents for psoriasis. A systematic review. J Rheumatol. 2006;33:1442–6.
Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Boehncke WH, de Vlam K, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009;68:1387–94.
Coates LC, Kavanaugh A, Ritchlin CT, GRAPPA Treatment Guideline Committee. Systemic review of treatments for psoriatic arthritis: 2014 update for GRAPPA. J Rheumatol. 2014;41:2273–6.
Acosta Felquer ML, Coates LC, Soriano ER, Ranza R, Espinoza LR, Helliwell PS, et al. Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review. J Rheumatol. 2014;41:2277–85.
Nash P, Lubrano E, Cauli A, Taylor W, Gladman DD, Chandran V. Updated guidelines for the management of axial disease in psoriatic arthritis. J Rheumatol. 2014;41:2286–9.
Orbai AM, Weitz J, Siegel EL, Siebert S, Savage LJ, Aydin SZ, et al. Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis. J Rheumatol. 2014;41:2290–4.
Rose S, Toloza S, Bautista-Molano W, Helliwell PS, GRAPPA Dactylitis Study Group. Comprehensive treatment of dactylitis in psoriatic arthritis. J Rheumatol. 2014;41:2295–3000.
Wolf-Henning Boehncke WH, David Alvarez Martinez D, James A, Solomon JA, Gottlieb AB. Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review. J Rheumatol. 2014;41:2301–5.
Armstrong AW, Tuong W, Love TJ, Carneiro S, Grynszpan R, Lee SS, Kavanaugh A. Treatments for nail psoriasis: a systematic review by the GRAPPA nail psoriasis work group. J Rheumatol. 2014;41:2306–14.
Ogdie A, Schwartzman S, Coates L, Eder L, Maharaj A, Zisman D, et al. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extra-articular manifestations. J Rheumatol. 2014;41:2315–22.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gladman, D.D., Mease, P.J., Helliwell, P.H. (2016). GRAPPA Historical Perspective. In: Adebajo, A., Boehncke, WH., Gladman, D., Mease, P. (eds) Psoriatic Arthritis and Psoriasis. Springer, Cham. https://doi.org/10.1007/978-3-319-19530-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-19530-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19529-2
Online ISBN: 978-3-319-19530-8
eBook Packages: MedicineMedicine (R0)